NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan
· Delayed Price · Currency is TWD 23.60
+0.05 (0.21%)
Jun 6, 2025, 2:59 PM CST
TPEX:4732 Revenue
In the year 2024, NatureWise Biotech & Medicals had annual revenue of 224.32M TWD with 40.08% growth. NatureWise Biotech & Medicals had revenue of 93.53M in the half year ending December 31, 2024, a decrease of -18.02%.
Revenue
224.32M
Revenue Growth
+40.08%
P/S Ratio
5.19
Revenue / Employee
7.01M
Employees
32
Market Cap
1.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 224.32M | 64.18M | 40.08% |
| Dec 31, 2023 | 160.14M | -68.45M | -29.94% |
| Dec 31, 2022 | 228.59M | -21.21M | -8.49% |
| Dec 31, 2021 | 249.80M | -57.12M | -18.61% |
| Dec 31, 2020 | 306.92M | -546.00K | -0.18% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Lumosa Therapeutics | 43.59M |
| Center Laboratories | 1.63B |
| Oneness Biotech | 117.33M |